Please login to the form below
Tonix appoints head of clinical development
Donald Kellerman has experience at Allergan, Map, Inspire and Glaxo Wellcome
Tonix Pharmaceuticals has appointed Dr Donald Kellerman to head the strategy and execution of its clinical programmes.
Dr Kellerman brings 30 years of industry experience to his new role as senior VP, clinical development and regulatory affairs.
This includes his most recent role as VP, scientific affairs for Allergan's inhalation products business. He took on this role after his previous company, Map Pharmaceuticals, was taken over by Allergan in 2013.
At Map, Dr Kellerman served as senior VP, clinical development and medical affairs at Map Pharmaceuticals having joined the company in 2008 from Inspire Pharmaceuticals.
He also has experience at GlaxoWellcome as director of respiratory clinical research.
Featured jobs
- Science Writer – Healthcare Advertising
-
Salary TBC
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Medical Writer, Healthcare Advertising
-
£35 - £45, 000 benefits
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
-
Scientific Engagement Director
-
Salary will be dependant on experience
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
Competitive salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Senior Strategic Planner, Healthcare Brand Communications, Londo...
-
Competitive Salary
- Account Director, Training & Medical Communications, London
-
Competitive Salary
-
Account Manager
-
£40, 000 - £45, 000 benefits
Subscribe to our email news alerts
- Roche starts new late-stage trials of Alzheimer’s candidate
- AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib
- Moving annual total (MAT)
- More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease
- Key success factor (KSF)
- Commentary: Roseanne’s racist tweet and Sanofi’s swift and surprising riposte
PMHub
Dovetail
Transforming healthcare through effective collaboration. Making work to feel proud of.
www.dovetailstrategies.com...
Latest intelligence
- 30 women leaders in UK healthcare (part 3)
- Part 3 of our list of thirty women leaders...
- 30 Women Leaders in UK Healthcare
- The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...
- 30 Women Leaders in UK Healthcare (part 2)
- Part two of our list of thirty women leaders 11-20...
Quick links
Infographics
